Immunome, Inc. IMNM
NASDAQ · United States · Health Technology
$20.94-0.58 (-2.67%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.65 | -0.51 | -26.5% | $0 | -100.0% | +9.0%$25.69→$27.99 |
| Q1 2026 | 2026-05-12 | -0.48 | -0.60 | +20.0% | — | — | -3.5%$23.00→$22.20 |
| Q4 2025 | 2026-03-03 | -0.76 | -0.57 | -33.3% | — | — | +1.4%$22.21→$22.52 |
| Q3 2025 | 2025-11-06 | -0.65 | -0.57 | -14.0% | — | — | -0.7%$15.35→$15.24 |
| Q1 2025 | 2025-05-12 | -0.52 | -0.57 | +8.8% | — | — | — |
| Q4 2024 | 2025-03-19 | -1.11 | -0.61 | -82.0% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.78 | -0.58 | -34.5% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.60 | -0.40 | -50.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.